Join us for an Information Session about the BLUE KNIGHT™ QuickFire Challenge. Ahead of the submission deadline approaching on July 22nd, attendees will have an opportunity to:
• Learn more about the Challenge’s key focus areas related to infectious disease, immunology, & the microbiome (more details below)
• Get the inside scoop on what makes an applicant stand out
• Learn the do’s and don’ts for submissions
• Ask questions to experts from Johnson & Johnson Innovation and BARDA
About the Challenge:
New infectious diseases have been emerging with increased frequency, furthering the likelihood of another pandemic or serious health threat occurring during our lifetime – potentially as soon as within the next decade.1 In today’s interconnected world, there is a greater need to work together to spark potential solutions for tomorrow’s known and unknown public health threats. New innovations, particularly those with multi-use potential, are needed to help rapidly and efficiently respond to emerging health security threats and infectious diseases.
BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness Response (ASPR) at the U.S. Department of Health and Human Services (HHS), seeks to answer this call by anticipating potential health security threats, activating the global innovation community, and amplifying scientific and technological advancements. That’s why Johnson & Johnson Innovation, together with BARDA, launched the BLUE KNIGHT™ QuickFire Challenge: Next-Generation Preparedness Solutions Application.
Innovators developing potentially ground-breaking ideas or technologies that aim to enhance preparedness solutions towards future known and unknown infectious disease threats are invited to submit ideas for up to $200,000 in total award funding and access to the global Johnson & Johnson Innovation – JLABS network through Blue Knight residency with mentorship from experts at the Johnson & Johnson Family of Companies and BARDA. Innovators must be developing potential preparedness solutions addressing at least one of the following QuickFire Challenge focus areas:
-Targeting the host response to known and unknown future infectious disease threats
-Enabling streamlined manufacturing of therapeutics and/or vaccines
-Leveraging the host microbiome
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
